The number of people with susceptibility test result for rifampicin in Hong Kong
Hong Kong: The number of people with susceptibility test result for rifampicin was 94.83 in 2021. ▬ Flat
Latest (2021)
94.83
Change on year
up 0.2%
World rank
52nd
of 146 countries
All-time high
100
in 2017
All-time low
92.65
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Hong Kong, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Hong Kong is 94.83, measured in 2021.
The figure is up 0.2% on the previous year and down 5.2% over five years.
Hong Kong ranks 52nd of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Hong Kong, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 100 | — |
| 2018 | 92.65 | -7.4% |
| 2019 | 95.91 | +3.5% |
| 2020 | 94.61 | -1.4% |
| 2021 | 94.83 | +0.2% |
Hong Kong compared with similar countries
- Hong Kong's 94.83 is above the median for high income countries, which is 92.6, 1.0× the median. (56 countries reporting)
- Hong Kong's 94.83 is below the median for East Asia & Pacific, which is 96.47, 98% of the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 96.18 | 92.65 | 100 | 3 |
| 2020s | 94.72 | 94.61 | 94.83 | 2 |
Countries ranked near Hong Kong
More health data for Hong Kong
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0171 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,924 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.73 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0137 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.11 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Hong Kong?
- The number of people with susceptibility test result for rifampicin in Hong Kong was 94.83 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Hong Kong?
- The highest recorded value was 100 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Hong Kong?
- The lowest recorded value was 92.65 in 2018.
- How does Hong Kong rank for the number of people with susceptibility test result for rifampicin?
- Hong Kong ranks 52nd out of 146 countries with data for 2021.
- Where does this Hong Kong data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).